Medidata Solutions (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its second quarter 2013 financial results before the open of the market on Thursday, July 25, 2013. Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will also hold a conference call at 8:00 a.m. ET for investors and analysts to discuss these results and business outlook.
To participate by telephone, domestic participants may dial 1-877-303-2528 and international participants may dial 1-847-829-0023. Those interested in participating in the conference call should dial in at least 10 minutes prior to the call to register.
Participants can also join the call via a simultaneous live audio webcast, which will be made available on the “Investor” section of Medidata's website, http://investor.mdsol.com.
A replay of the conference call can be accessed through August 8, 2013, by dialing 1-800-585-8367 domestically or 1-404-537-3406 internationally, with the passcode 17553261. An archive of the call will also be hosted on the “Investor” section of Medidata's website, http://investor.mdsol.com, for a limited period of time.About Medidata Solutions Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts